These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 2799764

  • 1. Plasma D dimer: a useful marker of fibrin breakdown in renal failure.
    Gordge MP, Faint RW, Rylance PB, Ireland H, Lane DA, Neild GH.
    Thromb Haemost; 1989 Jun 30; 61(3):522-5. PubMed ID: 2799764
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S.
    Rinsho Byori; 2004 Apr 30; 52(4):355-61. PubMed ID: 15164605
    [Abstract] [Full Text] [Related]

  • 4. Validity of plasma fibrinogen, D-dimer, and the von Willebrand factor as markers of cardiovascular morbidity in patients on chronic hemodialysis.
    Kirmizis D, Tsiandoulas A, Pangalou M, Koutoupa E, Rozi P, Protopappa M, Barboutis K.
    Med Sci Monit; 2006 Feb 30; 12(2):CR55-62. PubMed ID: 16449948
    [Abstract] [Full Text] [Related]

  • 5. Measurement of crosslinked fibrin derivatives in plasma and ascitic fluid with monoclonal antibodies against D dimer using EIA and latex test.
    Hafter R, Schröck R, von Hugo R, Graeff H.
    Scand J Clin Lab Invest Suppl; 1985 Feb 30; 178():137-44. PubMed ID: 3867114
    [Abstract] [Full Text] [Related]

  • 6. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE.
    Semin Vasc Med; 2005 Nov 30; 5(4):315-20. PubMed ID: 16302152
    [Abstract] [Full Text] [Related]

  • 7. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
    Trofatter KF, Howell ML, Greenberg CS, Hage ML.
    Obstet Gynecol; 1989 Mar 30; 73(3 Pt 1):435-40. PubMed ID: 2915868
    [Abstract] [Full Text] [Related]

  • 8. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T, Magari Y, Mizunaga S, Okabe E, Sumie A, Ishii T, Tomo T, Yasumori R, Nasu M.
    Nihon Jinzo Gakkai Shi; 1994 Jul 30; 36(7):805-12. PubMed ID: 8072218
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA, Dempfle CE, Matsuda M, Heene DL.
    Thromb Haemost; 1997 Sep 30; 78(3):1069-78. PubMed ID: 9308756
    [Abstract] [Full Text] [Related]

  • 11. Characterization of the pro-thrombotic state in CAPD patients.
    Preloznik Zupan I, Sabovic M, Salobir B, Buturovic Ponikvar J.
    Ren Fail; 2008 Sep 30; 30(6):597-602. PubMed ID: 18661409
    [Abstract] [Full Text] [Related]

  • 12. The Fibrin Assay Comparison Trial (FACT): evaluation of 23 quantitative D-dimer assays as basis for the development of D-dimer calibrators. FACT study group.
    Dempfle CE, Zips S, Ergül H, Heene DL, Fibrin Assay Comparative Trial study group.
    Thromb Haemost; 2001 Apr 30; 85(4):671-8. PubMed ID: 11341504
    [Abstract] [Full Text] [Related]

  • 13. Plasma D-dimer concentration in patients with systemic sclerosis.
    Marie I, Borg JY, Hellot MF, Levesque H.
    Br J Dermatol; 2008 Feb 30; 158(2):392-5. PubMed ID: 18028493
    [Abstract] [Full Text] [Related]

  • 14. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
    Nozawa T, Inoue H, Hirai T, Iwasa A, Okumura K, Lee JD, Shimizu A, Hayano M, Yano K.
    Int J Cardiol; 2006 Apr 28; 109(1):59-65. PubMed ID: 15992948
    [Abstract] [Full Text] [Related]

  • 15. [Soluble fibrin is not excreted in urine and its plasma level is elevated in nephrotic syndrome].
    Morikawa T, Yamashiro Y, Okano K, Kasamatsu M, Sugai H, Kitamura H, Ohba I, Hotta O, Taguma Y, Sakurai J, Kitamoto Y.
    Rinsho Byori; 2009 Apr 28; 57(4):319-23. PubMed ID: 19489432
    [Abstract] [Full Text] [Related]

  • 16. Weil's disease with elevated plasma D-dimer.
    Ohnishi K, Kato Y, Hayakawa K.
    Southeast Asian J Trop Med Public Health; 2006 Jan 28; 37(1):154-6. PubMed ID: 16771228
    [Abstract] [Full Text] [Related]

  • 17. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T, Poreba M, Mazur G, Poreba R, Pyszel A, Beck B, Steinmetz-Beck A, Andrzejak R, Kuliczkowski K.
    Neoplasma; 2006 Jan 28; 53(3):253-8. PubMed ID: 16652197
    [Abstract] [Full Text] [Related]

  • 18. [Role of fibrin D-dimer in acute coronary syndrome. Prospective study of 22 cases].
    Barakett N, Ouaddour A, Lahidheb D, Smiri Z, Mhenni H, Azzouzi F, Hajlaoui N, Salah O, Fehri W, Rahal N, Haouala H.
    Tunis Med; 2004 Jan 28; 82 Suppl 1():132-5. PubMed ID: 15127704
    [Abstract] [Full Text] [Related]

  • 19. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G, Monotti R, Haeberli A, Straub PW.
    Thromb Haemost; 1987 Aug 04; 58(2):758-63. PubMed ID: 3672428
    [Abstract] [Full Text] [Related]

  • 20. Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis.
    Kamikura Y, Wada H, Nobori T, Matsumoto T, Shiku H, Ishikura K, Yamada N, Nakano T, Kazahaya Y, Sawai T, Matsuda M.
    Thromb Res; 2005 Aug 04; 115(1-2):53-7. PubMed ID: 15567453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.